Press-release for stocks publishing date 2022 - 03

Prices are updated after-hours

| -32.63% | O: 1.97% H: 0.0% C: 0.0%
elunate approval china commercialization

HUTCHMED Receives Approval to Commercialize ELUNATE® in Macau
Published: 2022-03-01 (Crawled : 09:00) - globenewswire.com
HCM | $18.38 0.71% 43K

| -32.29% | O: 1.17% H: 4.14% C: 2.64%
BGNE | $143.32 3.12% 150K

| -32.63% | O: 1.97% H: 0.0% C: 0.0%
elunate approval commercialization

58%

42%

CSSE 4 | $0.3831 151.54% 190M

CZOO | $11.04 121.24% 11M

BOF | $1.87 59.83% 100M

AMST | $3.18 59.0% 67M

LICN | $0.85 51.79% 13M

WIMI | $1.04 43.37% 17M

SKIL 4 | $8.045 40.89% 230K

MULN | News | $3.805 39.38% 11M

RILY | $30.01 38.17% 11M

MTC | $3.04 35.71% 6.7M

Save your searches and get alerts when important news are released.